Nichol Ochsner | Vice President, Investor Relations |
Robert Finizio | Chief Executive Officer |
Daniel Cartwright | Chief Financial Officer |
Dawn Halkuff | Chief Commercial Officer |
Louise Chen | Cantor Fitzgerald |
Ken Cacciatore | Cowen |
Jay Olson | Oppenheimer |
Annabel Samimy | Stifel |
Chris Schott | JPMorgan |
Chris Howerton | Jefferies |
Good afternoon ladies and gentlemen. Thank you for joining us for the TherapeuticsMD First Quarter 2019 Financial Results Conference Call.
Following prepared remarks from the company, we will open the call for questions. I would now like to turn the conference call over to Therapeutics' Vice President of Investor Relations Nichol Ochsner.
Good afternoon everyone.